Back to News
AI
XtalPi Advances Hair Loss Drug Program into IND-Enabling Studies
PRNewswire·October 2, 2026·1 min read
AI Summary
The proprietary program targets a lactate–autophagy pathway to reactivate quiescent hair follicle stem cells.
From the source
The proprietary program targets a lactate–autophagy pathway to reactivate quiescent hair follicle stem cells. In a mouse model, a candidate achieved a hair-growth score comparable to that of 5% topical minoxidil at just 1/100 of the comparator's concentration…
The full text couldn't be loaded here (the source may require a subscription).
View original at PRNewswireKeep reading
Guest column: A caution about artificial intelligence - The Suffolk Timessuffolktimes.timesreview.com · 2h agoAI’s $4.7 trillion global opportunity: What it could mean for Indian companies and investors - Business Todaybusinesstoday.in · 3h agoOur AI panelists looks at the governance of artificial intelligence in light of the new U.S. accord - CBCcbc.ca · 3h agoAI models could harm young people's body image, warn experts - BBCbbc.com · 4h ago
Was this useful?